Oragenics Acquires Odyssey Health’s Neurological Drug Assets for Future Growth
Key Highlights Oragenics acquires assets related to Odyssey Health’s neurological drugs, including ONP-002 for concussion treatment and ONP-001 for…
Browsing Tag
Oragenics
1 post